Pricing & Access· July 15, 2026 · 21 min read
Topic
Payer Criteria
Clinical documentation, diagnosis, prior therapy, lab, severity, and renewal rules embedded in payer policies.
Pricing & Access· July 15, 2026 · 18 min read
Heart Failure Access Landscape 2026: GDMT, Entresto Generic, Kerendia, and Verquvo
By Ran Chen#Heart Failure#Payer Criteria#Cardiovascular
Pricing & Access· July 15, 2026 · 19 min read
IPF Access Landscape 2026: Jascayd, Ofev Generic entry, and Pirfenidone Pricing
Pricing & Access· July 13, 2026 · 20 min read
ATTR-CM Access Landscape: Tafamidis, Acoramidis, and Vutrisiran
By Ran Chen#Rare Disease#Payer Coverage#Payer Criteria
Pricing & Access· July 13, 2026 · 17 min read
Duchenne Muscular Dystrophy Access Landscape: Elevidys, Oligonucleotides, and Duvyzat
By Ran Chen#Rare Disease#Gene Therapy#HCPCS Coding
Pricing & Access· July 12, 2026 · 20 min read
Lupus and SLE Access: Benlysta, Saphnelo, Lupkynis, and Autoimmune CAR-T
By Ran Chen#Payer Coverage#Payer Criteria#CAR-T
Pricing & Access· July 12, 2026 · 20 min read
Severe Asthma Biologics: Access and Phenotype Matching Guide
By Ran Chen#Payer Coverage#Payer Criteria#Respiratory
Approvals· July 2, 2026 · 18 min read
Lifyorli (Relacorilant) FDA Approval and Ovarian Cancer Access
By Ran Chen#FDA Approval#Pivotal Trials#Payer Criteria
Biosimilars· June 21, 2026 · 6 min read
Soliris NMOSD Exclusivity Expiration: Skinny Label & REMS Barriers for Bkemv
Pricing & Access· June 6, 2026 · 14 min read
GLP-1 reauthorization denial appeal: overturning PA renewal refusals
By Ran Chen#GLP-1#Prior Authorization#Payer Coverage